Oncolytics Biotech, Inc. (ONCY) Q3 2024 Earnings
ONCY·Reported November 12, 2024·Before market open
Diluted EPS came in at $-0.09, missed the $-0.08 consensus by $0.01.
Diluted EPS
$-0.09missed by $0.01
Consensus: $-0.08
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Oncolytics Biotech, Inc.'s Q3 2024 earnings report.
Oncolytics Biotech, Inc. (ONCY) reported Q3 2024 earnings on November 12, 2024 before market open.
Oncolytics Biotech, Inc. reported diluted EPS of $-0.09 for Q3 2024.
EPS missed the consensus estimate of $-0.08 by $0.01.